599 filings
Page 5 of 30
424B2
4kr5 lncnie2
8 Mar 21
Prospectus for primary offering
5:00pm
CORRESP
ibog6kwt92isc24spd
5 Mar 21
Correspondence with SEC
12:00am
CORRESP
3fnvzwji7ivpkrtw6d
5 Mar 21
Correspondence with SEC
12:00am
6-K
3cctp7iuq t7j9
4 Mar 21
Current report (foreign)
8:09am
UPLOAD
d7jny69jbkg q4
4 Mar 21
Letter from SEC
12:00am
6-K
gneq gtnewnlja8h9tjh
2 Mar 21
Portage Announces Filing of Third Quarter Financial Statements
8:13am
6-K
6kqkp3 940
1 Mar 21
Condensed Consolidated Interim Financial Statements
4:23pm
6-K
ekcf571a
25 Feb 21
Current report (foreign)
8:11am
F-3
co38i btsi3talz
24 Feb 21
Shelf registration (foreign)
5:22pm
CERT
n0yo1tx rqark17u
24 Feb 21
Certification of approval for exchange listing
5:04pm
8-A12B
oymwxja4 5orpgs
18 Feb 21
Registration of securities on exchange
12:46pm
6-K
8y1s545b2jc7 q0oo0s
11 Feb 21
Portage Biotech Provides Research and Development Update and Announces Nasdaq Listing Approval
4:30pm
6-K
z4ryb16 ddraum
1 Dec 20
Condensed Consolidated Interim Financial Statements
7:13am
6-K
yfug20oi20alvvv8nxb3
16 Oct 20
Portage Announces Filing of Q1 Interim Financial Statements; Correction to Salvarx Loan Note Settlement Announcement
4:12pm
6-K
28ze y2fzc0
16 Oct 20
Consolidated Interim Financial Statements
2:44pm
6-K
p3mwi
13 Oct 20
Portage Issues Common Shares and Warrants In Settlement of Salvarx Loan Note Obligations
10:15am
NT 20-F
qjwx3r5y
31 Jul 20
Notice of late annual filing (foreign)
2:51pm
6-K
isfjhpls on2r7n31q
30 Jun 20
Report of Foreign Private Issuer
1:11pm
6-K
z3031od 4f
17 Jun 20
Report of Foreign Private Issuer
10:46am